The FRESH Study: Treatment of Intracranial Aneurysms with the New FRED X Flow Diverter with Antithrombotic Surface Treatment Technology—First Multicenter Experience in 161 Patients

references

1. 1.↵
   1. Lv X,
   2. Yang H,
   3. Liu P, et al

   . Flow-diverter devices in the treatment of intracranial aneurysms: a meta-analysis and systematic review. Neuroradiol J 2016;29:66–71 doi:10.1177/1971400915621321 pmid:26838174

   CrossRefPubMed
2. 2.↵
   1. Mohlenbruch MA,
   2. Kizilkilic O,
   3. Killer-Oberpfalzer M, et al

   . Multicenter experience with FRED Jr Flow Re-Direction Endoluminal Device for intracranial aneurysms in small arteries. AJNR Am J Neuroradiol 2017;38:1959–65 doi:10.3174/ajnr.A5332 pmid:28798217

   Abstract/FREE Full Text
3. 3.↵
   1. Kallmes DF,
   2. Brinjikji W,
   3. Boccardi E, et al

   . Aneurysm Study of Pipeline in an Observational Registry (ASPIRe). Interv Neurol 2016;5:89–99 doi:10.1159/000446503 pmid:27610126

   CrossRefPubMed
4. 4.↵
   1. Brinjikji W,
   2. Murad MH,
   3. Lanzino G, et al

   . Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke 2013;44:442–47 doi:10.1161/STROKEAHA.112.678151 pmid:23321438

   Abstract/FREE Full Text
5. 5.↵
   1. Fiehler J,
   2. Ries T

   . Prevention and treatment of thromboembolism during endovascular aneurysm therapy. Klin Neuroradiol 2009;19:73–81 doi:10.1007/s00062-009-8029-9 pmid:19636680

   CrossRefPubMed
6. 6.↵
   1. Ihn YK,
   2. Shin SH,
   3. Baik SK, et al

   . Complications of endovascular treatment for intracranial aneurysms: management and prevention. Interv Neuroradiol 2018;24:237–45 doi:10.1177/1591019918758493 pmid:29466903

   CrossRefPubMed
7. 7.↵
   1. Marosfoi M,
   2. Clarencon F,
   3. Langan ET, et al

   . Acute thrombus formation on phosphorilcholine surface modified flow diverters. J Neurointerv Surg 2018;10:406–11 doi:10.1136/neurintsurg-2017-013175 pmid:28689183

   Abstract/FREE Full Text
8. 8.↵
   1. King RM,
   2. Langan ET,
   3. Ughi GJ, et al

   . Acute thrombus burden on coated flow diverters assessed by high frequency optical coherence tomography. Cardiovasc Intervent Radiol 2020;43:1218–23 doi:10.1007/s00270-020-02482-w pmid:32385610

   CrossRefPubMed
9. 9.↵
   1. Killer-Oberpfalzer M,
   2. Kocer N,
   3. Griessenauer CJ, et al

   . European multicenter study for the evaluation of a dual-layer flow-diverting stent for treatment of wide-neck intracranial aneurysms: the European Flow-Redirection Intraluminal Device Study. AJNR Am J Neuroradiol 2018;39:841–47 doi:10.3174/ajnr.A5592 pmid:29545252

   Abstract/FREE Full Text
10. 10.↵
    1. Mohlenbruch MA,
    2. Herweh C,
    3. Jestaedt L, et al

    . The FRED flow-diverter stent for intracranial aneurysms: clinical study to assess safety and efficacy. AJNR Am J Neuroradiol 2015;36:1155–61 doi:10.3174/ajnr.A4251 pmid:25721079

    Abstract/FREE Full Text
11. 11.↵
    1. Pierot L,
    2. Spelle L,
    3. Berge J, et al

    . SAFE study (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment): 1-year clinical and anatomical results. J Neurointerv Surg 2019;11:184–89 doi:10.1136/neurintsurg-2018-014261 pmid:30297539

    Abstract/FREE Full Text
12. 12.↵
    1. McDougall CG,
    2. Diaz O,
    3. Boulos A, et al

    . Safety and efficacy results of the Flow Redirection Endoluminal Device (FRED) stent system in the treatment of intracranial aneurysms: US pivotal trial. J Neurointerv Surg 2022;14:577–84 doi:10.1136/neurintsurg-2021-017469 pmid:34282038

    Abstract/FREE Full Text
13. 13.↵
    1. Gunaydin S,
    2. Farsak B,
    3. Kocakulak M, et al

    . Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)-coated extracorporeal circuits. Ann Thorac Surg 2002;74:819–24 doi:10.1016/s0003-4975(02)03796-7 pmid:12238845

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Nutter BT,
    2. Stammers AH,
    3. Schmer RG, et al

    . The rheological effects of X-Coating with albumin and hetastarch on blood during cardiopulmonary bypass. J Extra Corpor Technol 2004;36:36–43 pmid:15095839

    PubMed
15. 15.↵
    1. Kallmes DF,
    2. Hanel R,
    3. Lopes D, et al

    . International retrospective study of the Pipeline embolization device: a multicenter aneurysm treatment study. AJNR Am J Neuroradiol 2015;36:108–15 doi:10.3174/ajnr.A4111 pmid:25355814

    Abstract/FREE Full Text
16. 16.↵
    1. O'Kelly CJ,
    2. Krings T,
    3. Fiorella D, et al

    . A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents. Interv Neuroradiol 2010;16:133–37 doi:10.1177/159101991001600204 pmid:20642887

    CrossRefPubMed
17. 17.↵
    1. Mascitelli JR,
    2. Moyle H,
    3. Oermann EK, et al

    . An update to the Raymond-Roy occlusion classification of intracranial aneurysms treated with coil embolization. J Neurointerv Surg 2015;7:496–502 doi:10.1136/neurintsurg-2014-011258 pmid:24898735

    Abstract/FREE Full Text
18. 18.↵
    1. Pierot L,
    2. Spelle L,
    3. Berge J, et al

    . SAFE study (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment): 1-year clinical and anatomical results. J Neurointerv Surg 2019;11:184–189 doi:10.1136/neurintsurg-2018-014261 pmid:30297539

    Abstract/FREE Full Text
19. 19.↵
    1. McDougall CG,
    2. Diaz O,
    3. Boulos A, et al

    . Safety and efficacy results of the Flow Redirection Endoluminal Device (FRED) stent system in the treatment of intracranial aneurysms: US pivotal trial. J Neurointerv Surg 2022;14:577–584 doi:10.1136/neurintsurg-2021-017469 pmid:34282038

    Abstract/FREE Full Text
20. 20.↵
    1. Skukalek SL,
    2. Winkler AM,
    3. Kang J, et al

    . Effect of antiplatelet therapy and platelet function testing on hemorrhagic and thrombotic complications in patients with cerebral aneurysms treated with the Pipeline embolization device: a review and meta-analysis. J Neurointerv Surg 2016;8:58–65 doi:10.1136/neurintsurg-2014-011145 pmid:25385746

    Abstract/FREE Full Text
21. 21.↵
    1. Vollherbst DF,
    2. Cekirge HS,
    3. Saatci I, et al

    . First clinical multicenter experience with the new Pipeline Vantage flow diverter. J Neurointerv Surg 2023;15:63–69 doi:10.1136/neurintsurg-2021-018480 pmid:35172983

    Abstract/FREE Full Text
22. 22.↵
    1. Becske T,
    2. Kallmes DF,
    3. Saatci I, et al

    . Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology 2013;267:858–68 doi:10.1148/radiol.13120099 pmid:23418004

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Becske T,
    2. Brinjikji W,
    3. Potts MB, et al

    . Long-term clinical and angiographic outcomes following Pipeline Embolization Device treatment of complex internal carotid artery aneurysms: five-year results of the Pipeline for Uncoilable or Failed Aneurysms Trial. Neurosurgery 2017;80:40–48 doi:10.1093/neuros/nyw014 pmid:28362885

    CrossRefPubMed